Bicara Therapeutics
BCAX
Bicara Therapeutics (BCAX) news
Recent news
Bicara Therapeutics - appoints Jenn Larson as CFO effective August 12, 2026
AInvest Wire · Aug 11, 2026Bicara Therapeutics - appoints Ryan Cohlhepp as president & CEO effective January 2027
Bicara Therapeutics Inc. (Nasdaq: BCAX) has announced that Ryan Cohlhepp, PharmD, will assume the role of President and Chief Executive Officer effective January 2027. Cohlhepp, who currently serves on the company’s team and brings expertise in science and patient care, will succeed Claire…
AInvest Wire · Aug 11, 2026Bicara Therapeutics announces inducement grants under Nasdaq listing Rule 5635(c)(4)
AInvest Wire · Jul 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.